Literature DB >> 10991651

Apolipoprotein E epsilon2 may be a risk factor for sporadic frontotemporal dementia.

D J Lehmann, A D Smith, M Combrinck, L Barnetson, C Joachim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991651      PMCID: PMC1737079          DOI: 10.1136/jnnp.69.3.404

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

1.  Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses.

Authors:  Isabel Hernández; Ana Mauleón; Maiteé Rosense-Roca; Montserrat Alegret; Georgina Vinyes; Anna Espinosa; Oscar Sotolongo-Grau; James T Becker; Sergi Valero; Lluís Tarraga; Oscar L López; Agustín Ruiz; Mercè Boada
Journal:  Curr Alzheimer Res       Date:  2014-02       Impact factor: 3.498

2.  The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males.

Authors:  R Srinivasan; Y Davidson; L Gibbons; A Payton; A M T Richardson; A Varma; C Julien; C Stopford; J Thompson; M A Horan; N Pendleton; S M Pickering-Brown; D Neary; J S Snowden; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

3.  Frontotemporal dementia and primary progressive aphasia: an update.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

4.  Apolipoprotein E polymorphisms and primary glaucoma in Saudis.

Authors:  Najwa Mohammed Al-Dabbagh; Nourah Al-Dohayan; Misbahul Arfin; Mohammad Tariq
Journal:  Mol Vis       Date:  2009-05-04       Impact factor: 2.367

Review 5.  Aging, neurodegenerative disease, and traumatic brain injury: the role of neuroimaging.

Authors:  Carrie Esopenko; Brian Levine
Journal:  J Neurotrauma       Date:  2014-12-29       Impact factor: 5.269

6.  Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Authors:  Wen-Hua Su; Zhi-Hong Shi; Shu-Ling Liu; Xiao-Dan Wang; Shuai Liu; Yong Ji
Journal:  Oncotarget       Date:  2017-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.